Just in time for Thanksgiving, Paul Sax, M.D., provides a rundown of developments that infectious disease and HIV specialists can be grateful for over the past year.
As rates of sexually transmitted diseases surge, public health officials want physicians to step up screening and treatment of patients.
A dial-in hotline program in New York City has helped qualified patients access post-exposure prophylaxis (PEP) at their local pharmacies, raising the possibility that remote screening methods could be an important way to bolster PEP use.
The assistant professor of medicine at Northwestern University discusses the challenges, and rewards, of being a gay man involved in HIV research.
Three new trials of HIV prevention drugs seek to answer directly a question that researchers inside and outside the field of HIV have explicitly avoided for years: How do drugs work -- and are they safe -- in pregnant and breastfeeding women?
Alicia Garza talks with TheBodyPRO's Kenyon Farrow about HIV's relative invisibility in black social justice spaces, despite its disproportionate impact on black communities.
There are multiple reasons why re-entry into communities from prison for black men with HIV is a difficult proposition, according to a recent study.
People living with HIV whose virus is completely, durably suppressed by treatment will not sexually transmit the virus to an HIV-negative partner, according to NIAID Director Anthony S. Fauci, M.D.
The risk of transmitting HIV through the breastmilk of virally suppressed women in high-income countries is not known.
The Infectious Diseases Society of America reported on June 29, 2018, that a new HIV acquisition had been found in a person using pre-exposure prophylaxis (PrEP).